# Altos Labs

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/altos-labs

- Industry: Biotechnology
- Headquarters: Redwood City, US
- Website: www.altoslabs.com/
- Total disclosed funding: $1.1B
- Latest round: Series B (Jan 19, 2022)
- Investors on record: 3

## About

Based in California, US, and founded in 2021, Altos Labs, Inc. aka Altos, is a biotechnology company focused on cellular rejuvenation programming. Hal Barron (CEO), Hans Bishop, and Richard Klausner are the co-founders of the company. In January 2022, Altos Labs, Inc. raised USD 800 million in series B funding from ARCH Venture Partners and Bezos Expedition. The series B funding values Altos Labs, Inc. at USD 3.29 billion post-money.

The company offers a range of scientific and technological services centered on cellular rejuvenation. Its core focus is on restoring cell health and resilience to reverse disease, injury, and age-related disabilities. The company conducts research in fundamental biology to understand how cells resist stressors and how this resistance can be restored. It develops applications based on partial cellular reprogramming, aiming to retain cell identity while enhancing youthful functions. Altos also operate the Institute of Computation, which builds AI-driven models to decode biological resilience at cellular and organism levels.

Altos Labs generates revenue by translating breakthrough science into breakthrough medicines. Its revenue streams include developing and commercializing therapies based on cellular rejuvenation, leveraging proprietary research in cell health and resilience.

## Funding rounds

- Series B, Jan 19, 2022, $800M — ARCH Venture Partners, Bezos Expeditions, 8VC
- Series A, Jun 13, 2021, $270M — ARCH Venture Partners, Bezos Expeditions

## Investors

- ARCH Venture Partners (https://capitalatlas.ai/funds/arch-venture-partners) — Series A, Series B
- Bezos Expeditions — Series A, Series B
- 8VC (https://capitalatlas.ai/funds/8vc) — Series B